Ottavio V. Vitolo

Ottavio is a neuropsychiatrist with more than 20 years of experience in translational research and clinical development in common and rare neurological and psychiatric conditions.

He served in roles of increasing responsibility in pharma and biotech companies including Shire, Pfizer, Homology Medicines, and Relmada Therapeutics and Alcyone Therapeutics, where he was head of R&D and CMO. Ottavio also maintains a clinical practice at MGH in Boston and a teaching position at Harvard Medical School.